Many Eagan patients who've cycled through multiple medications for depression, anxiety, pain, or cardiovascular conditions assume their condition is simply difficult to manage. In some cases, that's accurate—but in others, genetic factors affecting how they metabolize specific medications play a significant role. Standard prescribing applies population-based protocols that assume average metabolism, but individual variation in drug-processing enzymes means a dose that works well for most patients may be insufficient or produce unwanted effects for others.

Pharmacogenetic testing at True North Medical Care analyzes the specific genetic variants that affect metabolism of commonly prescribed drug classes. Rather than discovering through failed trials that your metabolism doesn't match population averages, PGx results provide that information before or alongside new prescribing decisions. The result is fewer medication changes driven by side effects or lack of response, and faster progress toward approaches that work within your individual metabolic profile.

PGx testing is most effective when integrated into a broader clinical evaluation that also considers your health history, organ function, concurrent medications, and the specific condition being managed. Testing alone doesn't prescribe—it informs clinical judgment that accounts for your complete situation.

The difference between PGx-guided prescribing and standard approaches shows most clearly in situations where multiple medications in the same class have already been tried. Genetic data changes how your provider approaches the next decision.

• Rapid metabolizer status for antidepressants may explain why standard doses didn't maintain consistent therapeutic drug levels over time
• Poor metabolizer status for pain medications can account for side effects that appeared at doses well within published normal ranges
• Intermediate metabolizer variants for cardiovascular drugs may warrant dose considerations to achieve intended treatment targets
• Pharmacogenetic data for multiple concurrent medications identifies which share metabolic pathways, helping manage interaction risk more systematically
• For Eagan patients starting new long-term treatment, PGx results can inform first-choice drug selection rather than applying genetic insight after previous options have already failed

Contact us to discuss pharmacogenetic testing in Eagan and whether genetic analysis fits your medication history and current treatment situation.

Pharmacogenetic testing is a clinical tool, not a universal solution. Understanding when it provides the most meaningful guidance helps Eagan patients determine whether testing fits their current situation.

• Whether multiple prior medication challenges in the same drug class warrant genetic analysis as part of a systematic next step in care
• How strongly the clinical picture suggests genetics may be contributing to unexplained side effects or suboptimal treatment response
• Whether the medication classes being considered are among those where PGx evidence is most clinically established and applicable
• How pharmacogenetic results will be interpreted alongside your health history, organ function, and concurrent medications rather than as standalone prescribing guidance
• Whether Eagan patients in your situation benefit most from PGx testing now versus other clinical priorities given your current treatment status and goals

Pharmacogenetic testing provides one layer of information within a comprehensive clinical evaluation. Schedule a consultation in Eagan to discuss whether PGx analysis fits your treatment history and what genetic data would add to your current care plan.